AGRX

Agile Therapeutics Inc
0.2399
0.0298 (14.18%)

Agile Therapeutics Inc. (AGRX) Fundamentals

Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin.
SHARE INFORMATION
Market CapUS$ 9,773,033
Shares Outstanding46,538,250
Float46,464,735
Percent Float99.84%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 4,102,000
Latest Fiscal EPSUS$ -31.20
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions59
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months448,262
Institutional Holdings Percent5.7%
Institutional Sold Previous 3 Months343,464
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months-
Insider Holdings Percent1.6
Insider Sold Previous 3 Months-
Insider Shares Owned747,697
TRADING INFO
52 Week HighUS$ 11.40
52 Week LowUS$ 0.18
52 Week High ChangeUS$ -97.95
21 Day Moving AverageUS$ 0.2365
21 Day Extended Moving AverageUS$ 0.233505
50 Day Moving AverageUS$ 0.2625
50 Day Extended Moving AverageUS$ 0.247253
200 Day Moving AverageUS$ 0.434658
200 Day Extended Moving AverageUS$ 3.2775
10 Day Average Volume295,999
20 Day Average Volume333,408
30 Day Average Volume428,882
50 Day Average Volume681,561
Alpha-0.053359
Beta1.1321
Standard Deviation0.328566
R20.034428
7 Day Price ChangeUS$ -0.0035
7 Day Percent Change-1.64%
21 Day Price ChangeUS$ -0.0312
21 Day Percent Change-12.94%
30 Day Price ChangeUS$ -0.0552
30 Day Percent Change-20.81%
Month to Date Price ChangeUS$ -0.0299
Month to Date Percent Change-12.46%
Quarter to Date Price ChangeUS$ -0.017
Quarter to Date Percent Change-7.49%
180 Day Price ChangeUS$ -0.1629
180 Day Percent Change-43.68%
200 Day Price ChangeUS$ -0.2138
200 Day Percent Change-50.45%
Year to Date Price ChangeUS$ -0.017
Year to Date Percent Change-7.49%

Agile Therapeutics Inc. (AGRX) Key Ratios

PROFITABILITY
EBIT Margin-809.2%
EBITDA Margin-785.1%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin-29.5%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 6,888,000
Revenue Per ShareUS$ 0.148
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.60
Total Debt To Equity0.30
Int Coverage-18.20
Current Ratio1.30
Leverage Ratio6.80
Quick Ratio0.80
Long Term Debt To Capital0.08
VALUATION MEASURES
PE Ratio0.00
Enterprise ValueUS$ 5,773,032
Price to Sales1.4188
Price to Free Cash-0.30
PE High Last 5 Years-4.30
Price To Book1.60
Price To Cash Flow0.00
PE Low Last 5 Years-3.50
Price to Tangible Book1.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.70
Invoice Turnover8.30
Assets Turnover0.30
Return Assets-270.54
Return on Equity-875.51
Return on Capital-356.40

Agile Therapeutics Inc. (AGRX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOAlfred F. Altomari
Emplyoees30
Last AuditUE
CIK0001261249
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address500 College Road East
Suite 310
Princeton, NJ 8540
Websitehttps://www.agiletherapeutics.com
Facsimile-
Telephone+1 609 683-1880
Emailinfo@agiletherapeutics.com
Your Recent History
NASDAQ
AGRX
Agile Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230322 00:04:44